Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9549979 Arabinogalactan for enhancing the adaptive immune response

Patent 9549979 was granted and assigned to Lonza Group on January, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ulla Freitas0

Bryan Rodriguez0

Jay Udani0

Kevin Q. Owen0

Date of Patent

January 24, 2017

0

Patent Application Number

150890910

Date Filed

April 1, 2016

0

Patent Primary Examiner

0

Patent abstract

The present invention discloses a composition containing Arabinogalactan for enhancing the adaptive immune response in subjects to foreign antigen(s) by administering said composition prior, during and after the phase of exposure to said foreign antigen(s). Furthermore, the present invention relates to a vaccination kit comprising a composition comprising Arabinogalactan and a vaccine.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9549979 Arabinogalactan for enhancing the adaptive immune response

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.